Manufacturer copay assistance · Bivigam (J1556) · ADMA Biologics
$75/dose · Maximum benefit Up to $6,000 per calendar year · Covers Bivigam drug cost and infusion administration — does not cover office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Bivigam — check the full fund board.
Yes — ADvantage Ig Co-pay Program from ADMA Biologics. Patient pays $75 per infusion. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Patient pays $75 per infusion Maximum benefit: Up to $6,000 per calendar year. Covers Bivigam drug cost and infusion administration — does not cover office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.